Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(+)- Epicatechin1件: Epicatechin---1件: 113
2(+)-Epicatechin1件: Epicatechin---1件: 113
3(-)-Epicatechin1件: Epicatechin---2件: 86, 113
412 mg/kg GSK2402968----1件: 113
52011-2012 seasonal flu vaccine Intramuscular----2件: 3, 113
62011-2012 seasonal flu vaccine Subcutaneous----2件: 3, 113
729180.00.00, 34681.00.00, 34681.01.00, 34681.02.00----1件: 113
83 mg/kg GSK2402968----1件: 113
94-Benzyl-2-naphthalen-1-yl-1,2,4- thiadiazolidine-3,5-dione----1件: 113
104-benzyl-2-naphthalen-1-yl-1,2,4-thiadiazolidine-3,5-dione----1件: 113
115-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole----1件: 113
126 mg/kg GSK2402968----1件: 113
13750 mg metformin and 7.5 g L-citrulline daily p.o.2件: Citrulline,
Metformin		3件: D00944 ,
D04966 ,
D07706 		2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113
149 mg/kg GSK2402968----1件: 113
15AAV1-gamma-sarcoglycan vector injection----1件: 113
16ACE-031 (Extension of cohort 1 from core study, A031-03)----1件: 113
17ACE-031 (Extension of cohort 2 from core study, A031-03)----1件: 113
18ACE-031 (Extension of cohort 3 from core study, A031-03)----1件: 113
19ACE-031 0.5 mg/kg q4wk----1件: 113
20ACE-031 1.0 mg/kg q2wk----1件: 113
21ACE-083----2件: 10, 113
22Acetate1件: Acetate---43件: 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299
23Activity Monitor1件: Methamidophos---1件: 113
24Actonel Once a week 5mg film coated tablets1件: Risedronic acid3件: D00942 ,
D03234 ,
D08484 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 113
25Adeno-associated viral vector serotype 8 containing the human MD1 gene----1件: 113
26Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene----1件: 113
27Adeno-associated virus serotype 9 carrying the human fukutin-related protein and target sequence of the miR-208a----1件: 113
28ADENO-ASSOCIATED VIRUS SEROTYPE RH74 CONTAINING THE HUMAN MICRO-DYSTROPHIN GENE----1件: 113
29Albuterol1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 12, 13, 86, 89, 113, 231, 256, 299
30Allogeneic Cardiosphere-Derived Cells (CAP-1002)1件: CAP-1002---1件: 113
31Anti-myostati----1件: 113
32Anti-Myostatin Adnectin----1件: 113
33AOC 1001----1件: 113
34Arginine1件: Arginine1件: D02982 --11件: 46, 58, 67, 78, 96, 97, 98, 113, 210, 251, 299
35Aspirin1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬12件: 13, 22, 34, 46, 49, 51, 58, 86, 113, 158, 210, 231
36ATALUREN1件: Ataluren1件: D09323 --6件: 19, 113, 140, 246, 299, 329
37Ataluren 1000 mg1件: Ataluren1件: D09323 --1件: 113
38Ataluren 125 mg1件: Ataluren1件: D09323 --1件: 113
39Ataluren 250 mg1件: Ataluren1件: D09323 --1件: 113
40ATYR1940----1件: 113
41Autologous bone marrow mononuclear cell transplantation----1件: 113
42AVI-4658----1件: 113
43AVI-4658 (Eteplirsen)1件: Eteplirsen1件: D09900 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
44AVI-4658 (PMO)----1件: 113
45AVI-4658 for Injection----1件: 113
46Balance1件: Isoxaflutole---8件: 6, 11, 13, 81, 113, 122, 149, 299
47BBP-418----1件: 113
48Behavioral: CHDR Monitoring Remotely (MORE)----1件: 113
49Behavioral: Control Group Typically Developing----1件: 113
50Behavioral: Duchenne Muscular Dystrophy group with Deflazacort1件: Deflazacort1件: D03671 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
51Behavioral: Duchenne Muscular Dystrophy group with Prednisone/Predisolone1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
52Behavioral: Duchenne Muscular Dystrophy group without Corticosteroids therapy----1件: 113
53Behavioral: In-home Exercise Training----1件: 113
54Behavioral: Regular exercise----1件: 113
55Behavioral: Withings Blood Pressure Monitor1件: Methamidophos---1件: 113
56Behavioral: Withings Body+ scale----1件: 113
57Behavioral: Withings Steel HR----1件: 113
58Betaloc ZOK 100, 95 mg----1件: 113
59Betaloc ZOK 25, 23,75 mg----1件: 113
60BIO101----1件: 113
61Biological: Umbilical Cord Based Allogenic Mesenchymal Stem Cell----1件: 113
62BISOPROLOL1件: Bisoprolol2件: D00634 ,
D02342 		1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 67, 86, 113
63Bisoprolol Fumarate1件: Bisoprolol2件: D00634 ,
D02342 		1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 113
64Bisphosphonate treatment----2件: 113, 299
65Blood test----6件: 36, 51, 86, 113, 162, 299
66BLS-M22----1件: 113
67BMN 044----1件: 113
68BMN 044 IV 6 mg/kg----1件: 113
69BMN 044 IV 9 mg/kg----1件: 113
70BMN 044 SC 6 mg/kg----1件: 113
71BMN 045----1件: 113
72BMN 053----1件: 113
73BMN053----1件: 113
74BMS-986089----1件: 113
75BMS-986089-01 (RO7239361) , anti-myostatin----1件: 113
76BMS-986089-01 (RO7239361) Injections, 15 mg/Syringe (21.4 mg/mL)----1件: 113
77BMS-986089-01 (RO7239361) Injections, 35 mg/Syringe (50 mg/mL)----1件: 113
78BMS-986089-01 (RO7239361) Injections, 50 mg/Syringe (71.4 mg/mL)----1件: 113
79BMS-986089-01 (RO7239361) Injections, 7.5 mg/Syringe (10.7 mg/mL)----1件: 113
80BMS-986089-01 (RO7239361), anti-myostatin----1件: 113
81BMS-986089-01 Injections, 15 mg/Syringe (21.4 mg/mL)----1件: 113
82BMS-986089-01 Injections, 35 mg/Syringe (50 mg/mL)----1件: 113
83BMS-986089-01 Injections, 50 mg/Syringe (71.4 mg/mL)----1件: 113
84BMS-986089-01 Injections, 7.5 mg/Syringe (10.7 mg/mL)----1件: 113
85BMS-986089-01, Anti-myostatin----1件: 113
86Bocidelpar----1件: 113
87BOTULINUM TOXIN TYPE A1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬10件: 2, 5, 6, 7, 13, 15, 17, 70, 113, 149
88Cabaletta1件: Trehalose---2件: 18, 113
89Calcichew D3 Forte----1件: 113
90CALCIFEDIOL1件: Calcifediol1件: D00122 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 113
91Canakinumab1件: Canakinumab1件: D09315 1件: IL1B 💬44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬10件: 46, 56, 84, 106, 107, 108, 113, 266, 267, 269
92Canakinumab Injection [Ilaris]1件: Canakinumab1件: D09315 1件: IL1B 💬44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 113
93CAP-10021件: CAP-1002---1件: 113
94Cardicor----1件: 113
95Cardicor (Merck brand)----1件: 113
96Cardiovascular profile----1件: 113
97Carvedilol1件: Carvedilol2件: D00255 ,
D03415 		5件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
ADRB2 💬		13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 6, 57, 86, 113, 210
98CASIMERSEN1件: Casimersen1件: D11988 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
99CAT-1004----1件: 113
100Chronic Corticosteroid Therapy----1件: 113
101Cialis 10 mg film-coated tablets1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113
102Cialis 2.5 mg film-coated tablets1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113
103Cialis 20 mg film-coated tablets1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113
104Cialis 5 mg film-coated tablets1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113
105Citrulline1件: Citrulline1件: D07706 --2件: 86, 113
106Coenzyme Q101件: Ubidecarenone1件: D01065 --12件: 2, 5, 6, 8, 10, 18, 46, 57, 113, 193, 214, 215
107Coenzyme Q10 and Lisinopril2件: Lisinopril,
Ubidecarenone		3件: D00362 ,
D01065 ,
D08131 		1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 113
108Cosintropina acetato----1件: 113
109Cosyntropin1件: Tetracosactide1件: D00284 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 83, 113, 145
110Cosyntropin acetate2件: Acetate,
Tetracosactide		1件: D00284 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 113
111Cr13C----1件: 113
112CRD007----1件: 113
113Creatine1件: Creatine---16件: 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 113, 156, 201, 256
114Creatine Monohydrate1件: Creatine---4件: 2, 8, 113, 156
115Creatine-13C1件: Creatine---1件: 113
116Cyclosporin1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬17件: 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326
117Cyclosporin A1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬11件: 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164
118Decortin----2件: 46, 113
119DEFLAN*10CPR 6MG----1件: 113
120Deflazacort1件: Deflazacort1件: D03671 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 30, 113
121Deflazacort 6 mg Tablets1件: Deflazacort1件: D03671 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
122Dehydroepiandrosterone1件: Prasterone1件: D08409 3件: AR,
ESR1,
ESR2 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬5件: 49, 53, 83, 96, 113
123Dehydroepiandrosterone 100 and 400 mg1件: Prasterone1件: D08409 3件: AR,
ESR1,
ESR2 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 113
124DELTACORTENE*20CPR 5MG----3件: 49, 97, 113
125DEXMEDETOMIDINE1件: Dexmedetomidine2件: D00514 ,
D01205 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬13件: 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280
126DHA----8件: 6, 46, 48, 49, 94, 113, 299, 301
127Diagnostic Test: 30 seconds sit to stand test----1件: 113
128Diagnostic Test: Beck depression inventory----1件: 113
129Diagnostic Test: Berg balance scale1件: Isoxaflutole---1件: 113
130Diagnostic Test: Brief Pain Inventory Short-Form----1件: 113
131Diagnostic Test: DM1-ActivC----1件: 113
132Diagnostic Test: Fatigue and Daytime Sleepiness Scale----1件: 113
133Diagnostic Test: Functional Index-2----1件: 113
134Diagnostic Test: GSGC----1件: 113
135Diagnostic Test: Hand opening time----1件: 113
136Diagnostic Test: Manual muscle testing----1件: 113
137Diagnostic Test: McGill pain questionnaire----1件: 113
138Diagnostic Test: Myotonia (from Individualised Neuromuscular Quality of Life Questionnaire)----1件: 113
139Diagnostic Test: Myotonia Behaviour scale----1件: 113
140Diagnostic Test: Pressure pain threshold----4件: 3, 15, 113, 256
141Diagnostic Test: Quantitative muscle testing----1件: 113
142Diagnostic Test: Quick Motor Function Test----4件: 3, 15, 113, 256
143Diagnostic Test: R-PAct----1件: 113
144Diagnostic Test: Scale for Assessment and Rating of Ataxia----1件: 113
145Diagnostic Test: Six minute walking test----1件: 113
146DILATREND----1件: 113
147Dosing Extension----1件: 113
148Drisapersen1件: Drisapersen1件: D10114 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
149DRISAPERSEN SODIUM1件: Drisapersen1件: D10114 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
150DS-5141b----1件: 113
151EDASALONEXENT1件: Edasalonexent1件: D12181 1件: RELA 💬76件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, Mitophagy - animal, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬1件: 113
152EDG-5506----1件: 113
153EGCG1件: Epigallocatechin gallate---9件: 6, 8, 13, 17, 28, 85, 113, 206, 299
154EMD 87580----1件: 113
155EMEA/H/C/000638----1件: 113
156EMFLAZA® (DEFLAZACORT)1件: Deflazacort1件: D03671 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
157EnaHexal----1件: 113
158EnaHexal®, 10mg----1件: 113
159Enalapril1件: Enalapril2件: D00621 ,
D07892 		1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬6件: 19, 46, 66, 113, 210, 222
160EnalHexal®, 5 mg----1件: 113
161EPA----6件: 8, 46, 48, 49, 113, 301
162EPA and DHA----1件: 113
163Epicatechin1件: Epicatechin---2件: 86, 113
164Epigallocatechin1件: Epigallocatechin---5件: 8, 13, 28, 85, 113
165Epigallocatechin-Gallate1件: Epigallocatechin---1件: 113
166Eplerenone1件: Eplerenone1件: D01115 1件: NR3C2 💬1件: Aldosterone-regulated sodium reabsorption 💬4件: 75, 113, 210, 215
167ERX-963----1件: 113
168Esomeprazole1件: Esomeprazole4件: D01984 ,
D04056 ,
D07917 ,
D09339 		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬8件: 13, 46, 86, 98, 107, 113, 298, 299
169Esomeprazolo----1件: 113
170ETEPLIRSEN1件: Eteplirsen1件: D09900 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
171Eteplirsen Injection1件: Eteplirsen1件: D09900 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
172Eucardic----1件: 113
173EV substance code: SUB188638----1件: 113
174Exondys 511件: Eteplirsen1件: D09900 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
175EXONDYS 51™1件: Eteplirsen1件: D09900 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
176Ezutromid1件: Ezutromid---1件: 113
177FG-3019----3件: 85, 113, 222
178Filgrastim1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬28件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331
179Flavocoxid----1件: 113
180FTX-1821----1件: 113
181Genetic: RNA extraction----1件: 113
182Gentamicin1件: Gentamicin2件: D01063 ,
D08013 		--3件: 36, 113, 299
183Gentamicin infusions twice a week for six months1件: Gentamicin2件: D01063 ,
D08013 		--1件: 113
184Givinostat1件: Givinostat---2件: 107, 113
185Givinostat (hydrochloride monohydrate)1件: Givinostat---1件: 113
186GIVINOSTAT (hyrochloride monohydrate)1件: Givinostat---1件: 113
187Givinostat (idrocloruro monoidrato)1件: Givinostat---1件: 113
188Glutamine1件: L-Glutamine1件: D00015 --7件: 87, 89, 96, 97, 113, 245, 299
189GNT0004----1件: 113
190GNT0006----1件: 113
191Gold1件: Gold---43件: 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 171, 193, 218, 222, 224, 227, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318
192GOLODIRSEN1件: Golodirsen1件: D11707 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
193Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53]1件: Golodirsen1件: D11707 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
194Granulocyte colony-stimulating factor (Filgrastim)1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 113
195GSK2402968----1件: 113
196GSK2402968 3mg/kg/week----1件: 113
197GSK2402968 6 mg/kg/week----1件: 113
198GSK2402968 6mg/kg/week----1件: 113
199Guanidine1件: Guanidine1件: D02437 --1件: 113
200H44AON188----1件: 113
201H51AON23----1件: 113
202Haemostasis tests----1件: 113
203HB-adMSCs1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---7件: 2, 4, 6, 13, 46, 49, 113
204HIDROFEROL----1件: 113
205Hidroferol®----1件: 113
206HLA-identical allogeneic mesoangioblasts----1件: 113
207HMABs----1件: 113
208Hormonal profile----1件: 113
209HT-100----1件: 113
210Human Umbilical Cord Mesenchymal Stem Cells1件: Human Umbilical Cord Mesenchymal Stem Cells---3件: 13, 96, 113
211Ibuprofen1件: Ibuprofen4件: D00126 ,
D01122 ,
D04490 ,
D06606 		2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬7件: 13, 46, 65, 107, 113, 271, 299
212IBUPROFEN 200MG1件: Ibuprofen4件: D00126 ,
D01122 ,
D04490 ,
D06606 		2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 113
213Idebenone1件: Idebenone1件: D01750 --6件: 6, 8, 13, 18, 113, 302
214Idebenone 150 mg film-coated tablets1件: Idebenone1件: D01750 --1件: 113
215Ifetroban1件: Ifetroban1件: D04500 1件: TBXA2R 💬3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬3件: 51, 86, 113
216IGF-1----1件: 113
217Increased exercise intensity----1件: 113
218Inflammatory profile----1件: 113
219IONIS-DMPKRx----1件: 113
220Isosorbide1件: Isosorbide dinitrate1件: D00516 --1件: 113
221ISOSORBIDE DINITRATE2件: Isosorbide,
Isosorbide dinitrate		2件: D00347 ,
D00516 		--1件: 113
222Isosorbide Dinitrate 20 mg1件: Isosorbide dinitrate1件: D00516 --1件: 113
223Isosorbide Dinitrate 40 mg1件: Isosorbide dinitrate1件: D00516 --1件: 113
224Isosorbide Dinitrate 60 mg2件: Isosorbide,
Isosorbide dinitrate		2件: D00347 ,
D00516 		--1件: 113
225Isosorbide Dinitrate 80 mg2件: Isosorbide,
Isosorbide dinitrate		2件: D00347 ,
D00516 		--1件: 113
226ITF2357----4件: 96, 107, 113, 267
227ITF2357 10 mg/mL----1件: 113
228KETAMINE1件: Ketamine2件: D00711 ,
D08098 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬6件: 6, 13, 70, 113, 156, 215
229L-arginine1件: Arginine1件: D02982 --3件: 46, 113, 299
230L-Citrulline and Metformin & L-Citrulline2件: Citrulline,
Metformin		3件: D00944 ,
D04966 ,
D07706 		2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113
231L-Glutamine1件: L-Glutamine1件: D00015 --2件: 113, 299
232Lentiviral Vector Trans-Skip gene modified Autologous Mesoangioblasts----1件: 113
233Lisinopril1件: Lisinopril2件: D00362 ,
D08131 		1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬7件: 19, 46, 49, 66, 67, 113, 222
234Lonafarnib1件: Lonafarnib1件: D04768 2件: FNTA,
FNTB 💬		1件: Terpenoid backbone biosynthesis 💬2件: 113, 333
235Losartan1件: Losartan2件: D00357 ,
D08146 		1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299
236LOSMAPIMOD1件: Losmapimod1件: D09639 4件: MAPK11,
MAPK12,
MAPK13,
MAPK14 💬		62件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬2件: 113, 222
237Lucen----1件: 113
238Mannitol1件: Mannitol1件: D00062 --7件: 6, 13, 28, 60, 96, 113, 299
239Metabolic profile----1件: 113
240Metformin1件: Metformin2件: D00944 ,
D04966 		2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬24件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301
241Metformin 500mg1件: Metformin2件: D00944 ,
D04966 		2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113
242Metformin and Metformin & L-Citrulline2件: Citrulline,
Metformin		3件: D00944 ,
D04966 ,
D07706 		2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113
243METFORMINA1件: Metformin2件: D00944 ,
D04966 		2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬2件: 67, 113
244METFORMINA - 500 30 COMPRESSE 500 MG1件: Metformin2件: D00944 ,
D04966 		2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113
245Methylphenidate1件: Methylphenidate2件: D01296 ,
D04999 		2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬7件: 6, 13, 34, 84, 113, 179, 206
246MetoHEXAL® Succ ® 23,75 mg Retardtabletten----1件: 113
247MetoHEXAL® Succ ® 47,5 mg Retardtabletten----1件: 113
248MetoHEXAL® Succ ® 95 mg Retardtabletten----1件: 113
249Metoprolol1件: Metoprolol3件: D00601 ,
D02358 ,
D05011 		1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 17, 57, 58, 113, 193, 226
250Metoprolol succinate1件: Metoprolol3件: D00601 ,
D02358 ,
D05011 		1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 57, 58, 113, 193
251Mexiletine1件: Mexiletine2件: D00639 ,
D08215 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬5件: 1, 2, 10, 113, 114
252Mexiletine 167 mg1件: Mexiletine2件: D00639 ,
D08215 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 113
253MNK-1411----1件: 113
254MONITOR1件: Methamidophos---20件: 2, 11, 13, 19, 28, 46, 49, 58, 65, 70, 81, 85, 86, 98, 113, 118, 129, 298, 299, 300
255Monocytes and megacaryocytes culture and RNA extraction----1件: 113
256Moxifloxacin1件: Moxifloxacin2件: D00874 ,
D08237 		--9件: 2, 6, 46, 49, 85, 86, 113, 240, 299
257Moxifloxacin Hydrochloride1件: Moxifloxacin2件: D00874 ,
D08237 		--2件: 113, 299
258MYO-0291件: MYO-029---1件: 113
259Myoblast autologous graft----1件: 113
260Myoblast transplantation----1件: 113
261Myoblastes autologues----1件: 113
262MYODM----1件: 113
263N(4,5Bis methanesulfonyl2methylbenzoyl) guanidine hydrochloride monohydrate1件: Guanidine1件: D02437 --1件: 113
264N-(4,5-Bis methanesulfonyl-2-methyl-benzoyl)guanidine hydrochloride monohydrate1件: Guanidine1件: D02437 --1件: 113
265Nanosuspension)----1件: 113
266Nebivolol1件: Nebivolol1件: D05127 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 17, 85, 113, 167
267Needle biopsy of the vastus lateralis muscle----1件: 113
268Nitrate1件: Nitrate1件: D02313 --3件: 58, 113, 299
269NPC-14----1件: 113
270NS-065/NCNP-01----1件: 113
271NS-089/NCNP-02----1件: 113
272Nébivolol----1件: 113
273Oligomero morfolino fosforodiamidato per skipping dell’esone 45----1件: 113
274Oligomero morfolino fosforodiamidato per skipping dell’esone 53----1件: 113
275Omigapil1件: Omigapil---1件: 113
276Other: beetroot juice extract----1件: 113
277Other: Dystrophin levels----1件: 113
278Other: Echocardiogram----1件: 113
279Other: Ibuprofen and Isosorbide Dinitrate combination2件: Ibuprofen,
Isosorbide dinitrate		5件: D00126 ,
D00516 ,
D01122 ,
D04490 ,
D06606 		2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 113
280Other: Magnetic Resonance Imaging (MRI)----1件: 113
281Other: Metabolic Exercise Testing using stationary bicycle----1件: 113
282Other: Pulmonary Function Testing (PFT)----1件: 113
283Other: Standard steroid treatment----1件: 113
284Oxatomide1件: Oxatomide1件: D01773 1件: ALOX5 💬6件: Arachidonic acid metabolism, Fc epsilon RI signaling pathway, Metabolic pathways, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis 💬1件: 113
285Oxatomide (tinset)1件: Oxatomide1件: D01773 1件: ALOX5 💬6件: Arachidonic acid metabolism, Fc epsilon RI signaling pathway, Metabolic pathways, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis 💬1件: 113
286P-188 NF----1件: 113
287PAMREVLUMAB1件: Pamrevlumab1件: D10969 1件: CCN2 💬2件: Apelin signaling pathway, Hippo signaling pathway 💬2件: 85, 113
288Pamrevlumab (FG-3019)1件: Pamrevlumab1件: D10969 1件: CCN2 💬2件: Apelin signaling pathway, Hippo signaling pathway 💬1件: 113
289PB1046 Injection----1件: 113
290PEMIROLAST1件: Pemirolast2件: D01088 ,
D07476 		--1件: 113
291Pending----6件: 13, 19, 96, 97, 113, 302
292Pentoxifylline1件: Pentoxifylline1件: D00501 --10件: 26, 56, 84, 93, 96, 113, 220, 222, 296, 298
293Peptide-conjugated phosphorodiamidate morpholino oligomer for exon 51 skipping----1件: 113
294Perindopril1件: Perindopril2件: D00624 ,
D03753 		1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬4件: 58, 113, 167, 222
295Perindopril 2mg Tablets1件: Perindopril2件: D00624 ,
D03753 		1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 113
296PF-062526161件: Domagrozumab1件: D11047 1件: MSTN 💬1件: Cytokine-cytokine receptor interaction 💬1件: 113
297PF-06939926----1件: 113
298PFT----3件: 89, 113, 299
299Phosphorodiamidate Morpholino Oligomer----1件: 113
300Phosphorodiamidate morpholino oligomer for exon 45 skipping----1件: 113
301Phosphorodiamidate morpholino oligomer for exon 53 skipping----1件: 113
302Pitolisant1件: Pitolisant1件: D10749 1件: HRH3 💬1件: Neuroactive ligand-receptor interaction 💬3件: 6, 113, 193
303Pitolisant Oral Tablet1件: Pitolisant1件: D10749 1件: HRH3 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
304Powder for Oral Suspension)----1件: 113
305PRD2175434----1件: 113
306PREDNISOLONE1件: Prednisolone8件: D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬43件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
307Prednison----3件: 46, 84, 113
308Prednisone1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬48件: 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331
309Prednisone 5 mg tablets1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
310Prednisone plus exercise1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
311Prednisone with daily edasalonexent2件: Edasalonexent,
Prednisone		2件: D00473 ,
D12181 		2件: NR3C1,
RELA 💬		77件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, Mitophagy - animal, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬1件: 113
312PRO044----1件: 113
313PRO044 IV----1件: 113
314PRO044 IV 6 mg/kg----1件: 113
315PRO044 IV 9 mg/kg----1件: 113
316PRO044 SC----1件: 113
317PRO044 SC 6 mg/kg----1件: 113
318PRO045----1件: 113
319PRO045, 0.15 mg/kg/week----1件: 113
320PRO045, 1.0 mg/kg/week----1件: 113
321PRO045, 3.0 mg/kg/week----1件: 113
322PRO045, 6.0 mg/kg/week----1件: 113
323PRO045, 9.0 mg/kg/week----1件: 113
324PRO045, selected dose----1件: 113
325PRO051----1件: 113
326PRO053----1件: 113
327Protein-carbohydrate supplementation----1件: 113
328Provigil1件: Modafinil1件: D01832 --2件: 13, 113
329PROVIGIL - 100 MG COMPRESSE 30 COMPRESSE1件: Modafinil1件: D01832 --1件: 113
330PS188----1件: 113
331PS188 (company code)----1件: 113
332PS220----1件: 113
333PS524----1件: 113
334PTC0161480, PTC124 Compound 1a, RPS2505, PTC-C124, 291844----1件: 113
335PTC124----4件: 19, 113, 246, 299
336RAAV1.CMV.huFollistatin344----2件: 15, 113
337RAAV1.CMV.huFollistin344----1件: 113
338RAAV2.5-CMV-minidystrophin (d3990)----1件: 113
339RAAV8-hMD1----1件: 113
340RAAV9-CK8-h-µD5----1件: 113
341RAAV9-hFKRPco_miR-208a----1件: 113
342RAAVrh74.MCK.GALGT2----1件: 113
343RAAVrh74.MCK.micro-Dystrophin----1件: 113
344Ramipril1件: Ramipril1件: D00421 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬7件: 46, 49, 66, 67, 113, 218, 257
345Ranolazine1件: Ranolazine2件: D05700 ,
D05701 		--6件: 2, 58, 86, 96, 113, 114
346Raxone1件: Idebenone1件: D01750 --1件: 113
347RAXONE - 150 MG- COMPRESSE RIVESTITE CON FILM- USO ORALE- FLACONE (HDPE)- 180 COMPRESSE1件: Idebenone1件: D01750 --1件: 113
348Recombinant human anti-GDF-8 antibody----1件: 113
349Regimen Selection Phase Group 1 (COMPLETED)----1件: 113
350Regimen Selection Phase Group 2----1件: 113
351Regimen Selection Phase Group 3----1件: 113
352Resveratrol1件: Resveratrol---6件: 2, 8, 18, 89, 113, 299
353Revatio1件: Sildenafil2件: D02229 ,
D08514 		1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬3件: 85, 86, 113
354RhIGF-I/rhIGFBP-31件: rhIGFBP-3---1件: 113
355RhIGFBP-31件: rhIGFBP-3---2件: 113, 195
356Rimeporide1件: Rimeporide---1件: 113
357Risedronate1件: Risedronic acid3件: D00942 ,
D03234 ,
D08484 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬7件: 46, 50, 66, 96, 107, 113, 274
358RISEDRONATE SODIUM1件: Risedronic acid3件: D00942 ,
D03234 ,
D08484 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬4件: 50, 107, 113, 274
359RO7239361----1件: 113
360RO7239361 (BMS-986089)----1件: 113
361RO7239361 Injections, 15 mg/Syringe (21.4 mg/mL)----1件: 113
362RO7239361 Injections, 35 mg/Syringe (50 mg/mL)----1件: 113
363RO7239361 Injections, 50 mg/Syringe (71.4 mg/mL)----1件: 113
364RO7239361 Injections, 7.5 mg/Syringe (10.7 mg/mL)----1件: 113
365Saline injection----1件: 113
366Sandimmun Optoral----2件: 53, 113
367ScAAV9.U7.ACCA----1件: 113
368ScAAVrh74.tMCK.hSGCA----1件: 113
369SGT-001----1件: 113
370Sildenafil1件: Sildenafil2件: D02229 ,
D08514 		1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301
371Sleep parameters----1件: 113
372SMT C1100----1件: 113
373SMT C1100 (F5----1件: 113
374SMT C1100 (F5)----1件: 113
375SMT C1100 (F6----1件: 113
376SMT C1100 (F6)----1件: 113
377SNT-MC17----1件: 113
378Sodium Nitrate2件: Nitrate,
Sodium nitrate		1件: D02313 --2件: 58, 113
379Sodium Nitrate - double dose2件: Nitrate,
Sodium nitrate		1件: D02313 --1件: 113
380SomatoKine/IPLEX----1件: 113
381Somatropin1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬19件: 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299
382Spironolactone1件: Spironolactone1件: D00443 1件: NR3C2 💬1件: Aldosterone-regulated sodium reabsorption 💬7件: 58, 67, 86, 113, 210, 218, 225
383SRP-4045----1件: 113
384SRP-4053----1件: 113
385SRP-5051----1件: 113
386SRP-9001----1件: 113
387Stem Cell----2件: 2, 113
388Stem Cells----4件: 2, 4, 96, 113
389Sunphenon----2件: 13, 113
390Sunphenon EGCG1件: Epigallocatechin gallate---3件: 13, 17, 113
391Sustanon----1件: 113
392Sustanon (testosterone)1件: Testosterone6件: D00075 ,
D00957 ,
D00958 ,
D00959 ,
D06085 ,
D06087 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113
393Sustanon 250----1件: 113
394Suvodirsen----1件: 113
395Synacthen Ampoules 250 mcg----1件: 113
396Synacthen Ampoules 250 microgrammi----1件: 113
397Tacrolimus1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
398Tadalafil1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬7件: 6, 51, 75, 84, 86, 113, 210
399Tadalafil 20 MG1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 113
400Tadalafil and Sildenafil2件: Sildenafil,
Tadalafil		3件: D02008 ,
D02229 ,
D08514 		1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 113
401Taking of blood----1件: 113
402TAMOX----1件: 113
403Tamoxifen1件: Tamoxifen2件: D00966 ,
D08559 		2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬4件: 2, 86, 113, 227
404Tamoxifen 20mg Hexal® Filmtabletten1件: Tamoxifen2件: D00966 ,
D08559 		2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 113
405TAMOXIFEN CITRATE1件: Tamoxifen2件: D00966 ,
D08559 		2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 113
406TAS-205----1件: 113
407Tehalose 30gr----1件: 113
408Temerit----1件: 113
409Testosterone1件: Testosterone6件: D00075 ,
D00957 ,
D00958 ,
D00959 ,
D06085 ,
D06087 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬9件: 1, 2, 3, 13, 60, 76, 78, 113, 265
410Testosterone decanoate2件: Testosterone,
Testosterone decanoate		7件: D00075 ,
D00957 ,
D00958 ,
D00959 ,
D06085 ,
D06087 ,
D08573 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113
411Testosterone Enanthate2件: Testosterone,
Testosterone enanthate		6件: D00075 ,
D00957 ,
D00958 ,
D00959 ,
D06085 ,
D06087 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113
412Testosterone isocaproate2件: Testosterone,
Testosterone isocaproate		6件: D00075 ,
D00957 ,
D00958 ,
D00959 ,
D06085 ,
D06087 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113
413Testosterone phenylpropionate2件: Testosterone,
Testosterone phenylpropionate		7件: D00075 ,
D00957 ,
D00958 ,
D00959 ,
D06085 ,
D06087 ,
D08574 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113
414Testosterone propionate2件: Testosterone,
Testosterone propionate		6件: D00075 ,
D00957 ,
D00958 ,
D00959 ,
D06085 ,
D06087 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 113
415Tetracosactide1件: Tetracosactide1件: D00284 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬4件: 83, 113, 145, 222
416TETRACOSACTIDE ESACETATO1件: Tetracosactide1件: D00284 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 113
417TETRACOSACTIDE HEXAACETATE1件: Tetracosactide1件: D00284 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 113
418Tideglusib1件: Tideglusib---2件: 5, 113
419Tinset----1件: 113
420To be determined----2件: 96, 113
421Tranilast1件: Tranilast1件: D02027 --4件: 46, 84, 106, 113
422Translarna1件: Ataluren1件: D09323 --1件: 113
423Translarna 1000 mg granules for oral suspension1件: Ataluren1件: D09323 --1件: 113
424Translarna 125 mg granules for oral suspension1件: Ataluren1件: D09323 --1件: 113
425Translarna 250 mg granules for oral suspension1件: Ataluren1件: D09323 --1件: 113
426Treatment Phase Group 4----1件: 113
427Trehalose1件: Trehalose---2件: 2, 113
428TRIATEC----1件: 113
429Umbilical Cord Mesenchymal Stem Cell----1件: 113
430Umbilical cord mesenchymal stem cells----5件: 13, 46, 57, 97, 113
431Vamarolone----1件: 113
432Vamorolone1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 97, 113
433Vamorolone 0.25 mg/day/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
434Vamorolone 0.25 mg/kg/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
435Vamorolone 0.75 mg/day/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
436Vamorolone 0.75 mg/kg/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
437Vamorolone 2.0 mg/day/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
438Vamorolone 2.0 mg/kg/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
439Vamorolone 6.0 mg/day/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
440Vamorolone 6.0 mg/kg/day1件: Vamorolone1件: D11000 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
441VBP15----1件: 113
442VILTOLARSEN1件: Viltolarsen1件: D11528 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
443Vit C Vit E Zn Se----1件: 113
444Vyondys 531件: Golodirsen1件: D11707 1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113
445WVE-210201----1件: 113
446WVE-210201 (suvodirsen)----1件: 113
447WVE-N531----1件: 113
448Xeomin1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬7件: 5, 6, 7, 13, 15, 17, 113
449Zn----2件: 113, 299